| Reference and Administrative Details |
||
|---|---|---|
| Trustees' Report |
2to5 | |
| Independent Examiner's Report |
6to 7 | |
| Consolidated Statement of Financial |
Activities | |
| Consolidated Balance Sheet |
||
| Balance Sheet | 10 | |
| Consolidated Statement ofCash Flows |
||
| Notes to the Financial Statements | 12to 25 |
| Total | Recognised G |
ains and Loss | es) |
|||
|---|---|---|---|---|---|---|
| Unrestricted | Restricted | Total | Total | |||
| funds | funds | 2022 | 2021 | |||
| Note | E | f. | F | |||
| Income and Endowments | from: | |||||
| Donations and legacies |
2 | 6,190 | 6,190 | 9,626 | ||
| Other trading activities |
3 | 289,426 | 289,426 | 202,161 | ||
| Investment income |
4 | 1,614 | 1,614 | 224 | ||
| Other income | 5 | 34,689 | ||||
| Total income | 297,230 | 297,230 | 246,700 | |||
| Expenditure on: |
||||||
| Raising funds | (217,175) | (217,175) | (178,555) | |||
| Charitable activities Other expenditure |
(77,563) ~(725 |
(77,563) (725 |
(109,922) (689 |
|||
| Total expenditure | (295,463) | (295,463 | (289,166) | |||
| Net income/(expenditure) | 1,767 | 1,767 | (42,466 | |||
| Net movement in funds |
1,767 | 1,767 | (42,466) | |||
| Reconciliation offunds |
||||||
| Total funds brought | forward | 505,029 | 440 | 505,469 | 547,935 | |
| Total funds carried | forward | tg | 506,796 | 440 | 507,236 | 505,469 |
| C | o | nsolidated Salance Sheet a |
s at 30Sept | ember 2022 | |
|---|---|---|---|---|---|
| 2022 | 2021 | ||||
| Note | |||||
| Fixed assets | |||||
| Tangible assets | 13 | 1,059 | 2,032 | ||
| Current assets | |||||
| Stocks Debtors Cash at bank and |
in | hand | 15 | 11,628 15,565 505,948 |
12,011 8,948 499,688 |
| 533,141 | 520,647 | ||||
| Creditors: Amounts | falling due within one year | 16 | (26,964) | (17,210) | |
| Net current assets | 506,177 | 503,437 | |||
| Net assets | 507,236 | 505,469 | |||
| Funds ofthe group: | |||||
| Restricted income |
funds | ||||
| Restricted funds |
440 | 440 | |||
| Unrestricted income |
funds | ||||
| Unrestricted funds |
506,796 | 505,029 | |||
| Total funds | 19 | 507,236 | 505,469 |
| 2022 | 2021 | |||||
|---|---|---|---|---|---|---|
| Note | f. | |||||
| Fixed assets | ||||||
| Investments | 100 | 100 | ||||
| Current assets | ||||||
| Debtors Cash at bank and |
in hand | 15 | 74,509 439,646 |
61,423 448,972 |
||
| 514,155 | 510,395 | |||||
| Creditors: | Amounts | falling due within one year | 16 | (3,540) | (2,520) | |
| Net current | assets | 510,615 | 507,875 | |||
| Net assets | 510,715 | 507,975 | ||||
| Funds ofthe charity: | ||||||
| Restricted | income | funds | ||||
| Restricted funds | 440 | 440 | ||||
| Unrestricted | income | funds | ||||
| Unrestricted | funds | 510,275 | 507,535 | |||
| Total funds | 510,715 | 507,975 |
| Consolidated Statemen |
t ofCash F | lows for | the Year En | ded 30Septem | ber 2022 |
|---|---|---|---|---|---|
| 2022 | 2021 | ||||
| Note | f. | ||||
| Cash flows from operating | activities | ||||
| Net cash income/(expenditure) | 1,767 | (42,466) | |||
| Adjustments to cash flows |
from noncash | items | |||
| Depreciation | 1,453 | 1,446 | |||
| Investment income |
1,614 | 224 | |||
| 1,606 | (41,244) | ||||
| Working capital adjustments | |||||
| Decrease/(increase) in stocks Increase in debtors Increase/(decrease) in creditors |
15 16 |
383 (6,617) 9,754 |
(423) (4,151) 451 |
||
| Net cash flows from operating | activities | 5,126 | 46,269 | ||
| Cash flows from investing activities |
|||||
| Interest receivable and similar |
income | 4 | 1,614 | 224 | |
| Purchase oftangible fixed assets |
13 | (480) | (978) | ||
| Net cash flows from investing | activities | 1,134 | 754 | ||
| Net increase/(decrease) in cash and cash equivalents |
6,260 | (47,023) | |||
| Cash and cash equivalents at |
1 October | 499,688 | 546,711 | ||
| Cash and cash equivalents at |
30 September | 505,948 | 499,688 |
| 2 Income |
from donati | ons and legacies |
|||
|---|---|---|---|---|---|
| Unrestricted | |||||
| funds | Total | Total | |||
| General | 2022 | 2021 | |||
| E | |||||
| Donations and legacies; |
|||||
| Donations | and gifts | 4,568 | 4,568 | 5,514 | |
| Legacies and funeral | donations | 762 | 762 | 2,980 | |
| Income tax and gift aid | 860 | 860 | 1,132 | ||
| 6,190 | 6,190 | 9,626 |
| 3 Inco |
me fro | m othe | r trading activities | |||
|---|---|---|---|---|---|---|
| Unrestricted | ||||||
| funds | Total | Total | ||||
| General | 2022 | 2021 | ||||
| Trading | income; | |||||
| Commercial | trading | operations | 288,689 | 288,689 | 202,156 | |
| Events | income; | |||||
| Other | events | income | 737 | 737 | ||
| 289,426 | 289,426 | 202,161 |
| Unrestricted | ||||||
|---|---|---|---|---|---|---|
| funds | Total | Total | ||||
| General | 2022 | 2021 | ||||
| F | ||||||
| Other | investment | income | 1,614 | 1,614 | 224 |
| Total | Total | |||
|---|---|---|---|---|
| 2022 | 2021 | |||
| F | F | |||
| Other operating CJRS income |
income | 1,082 3,931 |
||
| Insurance | payout | 29,676 | ||
| 34,689 |
| Unrestricted | ||||||
|---|---|---|---|---|---|---|
| funds | Total | Total | ||||
| General | 2022 | 2021 | ||||
| E | ||||||
| Fund-raising | and | publicity | 175 | 175 |
| b) Cos | ts oftradin | g activities |
||||
|---|---|---|---|---|---|---|
| Unrestricted | ||||||
| funds | Total | Total | ||||
| Note | General f |
2022 | 2021 | |||
| Trading | subsidiary | costs | 11 | 217,000 | 217,000 | 178,555 |
| 217,000 | 217,000 | 178,555 |
| 7 Expen |
di | ture on charitable activit |
ies | ||||
|---|---|---|---|---|---|---|---|
| Unrestricted | |||||||
| funds | Total | Total | |||||
| General | 2022 | 2021 | |||||
| Note | |||||||
| Support to Patients | 735 | 735 | |||||
| Allocated | support costs | 725 | 725 | 689 | |||
| Governance | costs | 3,710 | 3,710 | 2,520 | |||
| Donations | to YDH NHS Foundation | ||||||
| Trust | 73,118 | 73,118 | 107,402 | ||||
| 78,288 | 78,288 | 110,611 |
| Suppo | rt costs allocated | to charitable activities |
|||||
|---|---|---|---|---|---|---|---|
| Other | |||||||
| support | Total | Total | |||||
| Basis of | costs | 2022 | 2021 | ||||
| allocation | K | ||||||
| Attend | subscription | 100%support | 725 | 725 | 689 |
| Unrestricted | ||||||
|---|---|---|---|---|---|---|
| funds | Total | Total | ||||
| General | 2022 | 2021 | ||||
| F | f. | |||||
| Independent | examiner fees | |||||
| Examination Other fees |
ofthe financial statements paid to examiners |
1,525 2,185 |
1,525 2,185 |
1,380 1,140 |
||
| 3,710 | 3,710 | 2,520 | ||||
| 9 | Net incoming/outgoing | resources | ||||
| Net incoming/(outgoing) resources for the year include: |
| 2022 | 2021 | ||
|---|---|---|---|
| Independent Depreciation |
examiner's fees offixed assets |
3,710 1,453 |
2,520 1,446 |
| Sbid |
i | ||||
|---|---|---|---|---|---|
| usary Pr |
t and Loss | 2022 | 2021 | ||
| Turnover | 288,689 | 202,156 | |||
| Cost ofsales | (172,522) | (125,753) | |||
| Gross profit | 116,167 | 76,403 | |||
| Other operating | income | 347 | 35,952 | ||
| Administrative | expenses | (44,478) | (52,802) | ||
| Net Profit | 72,036 | 59,553 | |||
| Reserves brought forward |
57,515 | 59,467 | |||
| Distribution to The League ofFriends ofYeovil Hospitals |
(60,021) | (61,505) | |||
| Retained in Subsidiary |
|||||
| The assets and | liabilities ofthe subsidiary | were | 2022 | 2021 | |
| E | |||||
| Fixed assets | 1,059 | 2,032 | |||
| Current assets | 91,995 | 70,273 | |||
| Current liabilities |
(23,424) | (14,690) | |||
| Total net assets | 69,630 | 57,615 | |||
| Share capital | 100 | 100 | |||
| Reserves | 69,530 | 57,515 | |||
| Total equity | 69,630 | 57,615 |
| 12Staffcosts | 12Staffcosts | 12Staffcosts | |||
|---|---|---|---|---|---|
| The aggregate payroll costs were as follows: |
|||||
| 2022 | 2021 | ||||
| f. | |||||
| Staffcosts during the | year were: | ||||
| Wages and salaries | 35,615 | 43,079 | |||
| Staff pensions (defined |
contribution) | 1,366 | 1,360 | ||
| 36,981 | 44,439 | ||||
| The average number ofpersons employed |
during | the year was as follows: |
| Group | |||
|---|---|---|---|
| Fixtures and | Office | ||
| fittings | equipment | Total | |
| E | |||
| Cost | |||
| At 1 October 2021 | 13,915 | 978 | 14,893 |
| Additions Disposals |
480 559 |
480 ~(559 |
|
| At 30September 2022 | 13,836 | 978 | 14,814 |
| Depreciation | |||
| At 1 October 2021 | 12,665 | 196 | 12,861 |
| Charge for the year Eliminated on disposals |
1,297 559 |
156 | 1,453 ~559 |
| At 30September 2022 | 13,403 | 352 | 13,755 |
| Net book value | |||
| At 30September 2022 | 433 | 626 | 1,059 |
| At 30September 2021 | 1,250 | 782 | 2,032 |
| Subsidiary | ||
|---|---|---|
| undertakings | Total | |
| E | ||
| Cost | ||
| At 1 October 2021 | 100 | 100 |
| At 30September 2022 | 100 | 100 |
| Net book value | ||
| At 30September 2022 | 100 | 100 |
| At 30 September 2021 | 100 | 100 |
| 15Debtors | |||||
|---|---|---|---|---|---|
| Group 2022 |
2021 | 2022 | Charity | 2021 | |
| E | F | ||||
| Prepayments | 265 | 265 | |||
| Accrued income | 375 | 3 | 73,384 | 60,024 | |
| Other debtors | 14,925 | 8,945 | 860 | 1,399 | |
| 15,565 | 8,948 | 74,509 | 61,423 |
| 16Creditors: | amounts falling |
due within one year | |||
|---|---|---|---|---|---|
| Group 2022 |
2021 | 2022 Charity |
2021 | ||
| F | F | F | |||
| Trade creditors | 15,218 | 8,545 | |||
| Other taxation | and social | ||||
| security | 359 | 668 | |||
| VAT payable | 4,222 | 2,188 | |||
| Other creditors | 1,241 | 1,310 | |||
| Accruals | 5,924 | 4,499 | 3,540 | 2,520 | |
| 26,964 | 17,210 | 3,540 | 2,520 |
| Group | ||||||
|---|---|---|---|---|---|---|
| Balance at | ||||||
| Balance at | 30 | |||||
| 1 October 2021 f. |
Incoming resources E |
Resources expended |
Transfers | September 2022 |
||
| Unrestricted funds |
||||||
| General | ||||||
| Unrestricted general |
||||||
| funds | 169,771 | 297,230 | (267,601) | (140,520) | 58,880 | |
| Designated | ||||||
| Children's outpatients |
300,000 | (150,000) | 150,000 | |||
| Breast Cancer Unit | 100,000 | 100,000 | ||||
| New projects Other designated |
funds | 35,258 | ~27,662 | 150,000 40,520 |
150,000 47,916 |
|
| 335,258 | (27,862) | 140,520 | 447,916 | |||
| Total unrestricted | funds | 505,029 | 297,230 | ~(295,463 | 506,796 | |
| Restricted funds | ||||||
| Chemotherapy unit |
66 | 66 | ||||
| Macmillan unit Barrie |
||||||
| Ackland | 85 | 85 | ||||
| Ward 8BDaphne | I Tulk | 175 | 175 | |||
| Macmillan unit John Hicks |
114 | 114 | ||||
| Total restricted funds | 440 | 440 | ||||
| Total funds |
| Notes to the Financial | Statements for |
the Year End | ed 30Septem | ber 2022 |
|---|---|---|---|---|
| Balance at 1 October 2020 |
Incoming resources |
Resources expended |
Balance at 30 September 2021 |
|
| F | ||||
| Unrestricted funds |
||||
| General | ||||
| Unrestricted general funds |
163,246 | 246,700 | (240,175) | 169,771 |
| Designated | ||||
| Children's outpatients Other designated funds |
300,000 83,624 |
(48,366) | 300,000 35,258 |
|
| 383,624 | 48,366 | 335,258 | ||
| Total unrestricted funds |
546,870 | 246,700 | (288,541 | 505,029 |
| Restricted funds | ||||
| Chemotherapy unit |
66 | 66 | ||
| Macmillan unit Barrie Ackland Ward 8BDaphne I Tulk |
85 175 |
85 175 |
||
| Mrs H M Ward patients | ||||
| vouchers for shop Macmillan unit John Hicks |
625 114 |
(625) | 114 | |
| Total restricted funds |
1,065 | (625 | 440 | |
| Total funds | 547,935 | 246,700 | (289,166 | 505,469 |
| Group | |||||
|---|---|---|---|---|---|
| Total funds | |||||
| Unrestricted | at 30 | ||||
| funds General |
Restricted funds |
September 2022 |
|||
| E | |||||
| Tangible Current Current |
fixed assets assets liabilities |
1,059 532,701 26,964 |
440 | 1,059 533,141 26,964 |
|
| Total net assets | 506,796 | 440 | 507,236 | ||
| Total funds | |||||
| Unrestricted | at 30 | ||||
| funds General |
Restricted funds |
September 2021 |
|||
| Tangible Current Current |
fixed assets assets liabilities |
2,032 520,207 17,210 |
440 | 2,032 520,647 17,210) |
|
| Total net | assets | 505,029 | 440 | 505,469 |